Barth syndrome cardiomyopathy

2017 | review. A publication with affiliation to the University of Göttingen.

Jump to: Cite & Linked | Documents & Media | Details | Version history

Cite this publication

​Barth syndrome cardiomyopathy​
Dudek, J.& Maack, C.​ (2017)
Cardiovascular Research, 113​(4) pp. 399​-410​.​
Oxford Univ Press. DOI: https://doi.org/10.1093/cvr/cvx014 

Documents & Media

License

GRO License GRO License

Details

Authors
Dudek, Jan; Maack, Christoph
Abstract
Barth syndrome (BTHS) is an inherited form of cardiomyopathy, caused by a mutation within the gene encoding the mitochondrial transacylase tafazzin. Tafazzin is involved in the biosynthesis of the unique phospholipid cardiolipin (CL), which is almost exclusively found in mitochondrial membranes. CL directly interacts with a number of essential protein complexes in the mitochondrial membranes including the respiratory chain, mitochondrial metabolite carriers, and proteins, involved in shaping mitochondrial morphology. Here we describe, how in BTHS CL deficiency causes changes in the morphology of mitochondria, structural changes in the respiratory chain, decreased respiration, and increased generation of reactive oxygen species. A large number of cellular and animal models for BTHS have been established to elucidate how mitochondrial dysfunction induces sarcomere disorganization and reduced contractility, resulting in dilated cardiomyopathy in vivo.
Issue Date
2017
Status
published
Publisher
Oxford Univ Press
Journal
Cardiovascular Research 
ISSN
1755-3245; 0008-6363

Reference

Citations


Social Media